LifeSci Special Opportunities Responds to Recent Press Release Issued by Diffusion Pharmaceuticals

Stock Information for AMMO Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AMMO Inc.

Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci's History of Stockholder Value Destruction and Self-Dealing
Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.